What was Pasithea Therapeutics Corp.'s revenue in Q4 FY2022?

Pasithea Therapeutics Corp. reported total revenue of $240.7K in Q4 FY2022.

What was Pasithea Therapeutics Corp.'s net profit in Q4 FY2022?

Pasithea Therapeutics Corp. reported net profit of $-5.1M in Q4 FY2022, a net margin of -2126.1%.

What were Pasithea Therapeutics Corp.'s margins in Q4 FY2022?

Pasithea Therapeutics Corp. had operating margin of -1679.5% in Q4 FY2022.

What was Pasithea Therapeutics Corp.'s EPS in Q4 FY2022?

Pasithea Therapeutics Corp. reported diluted EPS of $-1.72 in Q4 FY2022.

Pasithea Therapeutics Corp.KTTAEarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

Deep Analysis

Pasithea Therapeutics Corp. is a clinical-stage biopharmaceutical firm dedicated to developing novel treatments for psychiatric and neurological conditions including treatment-resistant mood disorders. It primarily operates in North American and European markets, targeting patient segments that lack effective existing treatment options.

Q4 2022 Q3 2022 Q2 2022 Q1 2022

Revenue

$240.7K

Gross Profit

$242.0K

Operating Profit

$-4.0M

Net Profit

$-5.1M

Gross Margin

100.5%

Operating Margin

-1679.5%

Net Margin

-2126.1%

YoY Growth

N/A

EPS

$-1.72

Pasithea Therapeutics Corp. Q4 FY2022 Financial Summary

Pasithea Therapeutics Corp. reported revenue of $240.7K for Q4 FY2022, with a net profit of $-5.1M (-2126.1% margin).

Key Financial Metrics

Total Revenue	$240.7K
Net Profit	$-5.1M
Gross Margin	N/A
Operating Margin	-1679.5%
Report Period	Q4 FY2022

Pasithea Therapeutics Corp. Annual Revenue by Year

Pasithea Therapeutics Corp. annual revenue history includes year-by-year totals (for example, 2022 revenue was $486.6K).

Year	Annual Revenue
2022	$486.6K	vs 2021 →

Pasithea Therapeutics Corp. Quarterly Revenue & Net Profit History

Pasithea Therapeutics Corp. results over the last 4 reported quarters, including revenue, net profit and year-over-year growth.

Quarter	Revenue	Revenue YoY	Net Profit	Net Margin
Q4 FY2022	$240.7K	—	$-5.1M	-2126.1%
Q3 FY2022	$218.6K	+43133.1%	$-4.6M	-2097.9%
Q2 FY2022	$13.6K	—	$-2.7M	-19574.4%
Q1 FY2022	$13.7K	—	$-1.6M	-11526.1%

Income Statement

	Q1 2022	Q2 2022	Q3 2022	Q4 2022
Revenue	$13658	$13581	$218608	$240712
YoY Growth	N/A	N/A	43133.1%	N/A

Balance Sheet

	Q1 2022	Q2 2022	Q3 2022	Q4 2022
Assets	$51.1M	$53.0M	$49.6M	$45.2M
Liabilities	$1.1M	$1.6M	$2.8M	$2.7M
Equity	$50.0M	$51.3M	$46.8M	$42.5M

Cash Flow

	Q1 2022	Q2 2022	Q3 2022	Q4 2022
Operating CF	$-2.5M	$-2.4M	$-5.2M	$-4.4M